Skip to main content

Advertisement

Table 2 Mean intensity of JUNB, CXCR4, TYROBP, PRDX1, NFYA, and YWHAB in breast cancer cell lines, PBMCs, and CTCs

From: The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization

Mean intensity Normal PBMCs Patients PBMCs SKBR3 MCF7 MDA-MB 231 Hela Int CTCs
JUNB 5.2 ± 0.15 4.4 ± 0.11 26.1 ± 1.8 8.9 ± 0.56 6.6 ± 0.15 6.2 ± 0.65 9.6 ± 6.3
CXCR4 10.62 ± 1.01 25.4 ± 1.59 168.8 ± 8.25 13.86 ± 0.51 10.22 ± 0.7 26.85 ± 2.69 33.57 ± 9.25
TYROBP 5.17 ± 0.67 4.82 ± 0.21 3.97 ± 0.13 3.61 ± 0.1 5.08 ± 0.09 3.49 ± 0.24 8.89 ± 3.53
PRDX1 15.9 ± 3.62 34.73 ± 9.69 3.53 ± 0.22 6.25 ± 0.18 22.01 ± 1.64 4.83 ± 0.00 29.34 ± 24.65
NFYA 5.91 ± 0.52 6.08 ± 0.25 3.95 ± 0.23 4.93 ± 0.09 7.26 ± 0.15 5.41 ± 0.18 5.20 ± 1.36
YWHAB 26.13 ± 10.10 0 ± 0 4.04 ± 0.15 7.60 ± 0.12 26.45 ± 3.52 8.20 ± 0.4 5.70 ± 0.28